AIM Media House

AI Lifesciences

Latest AI Lifesciences news, analysis and insights from AIM Media House

Syneos Health Expands AI Partnerships to Scale Biopharma Commercial Operations

By AIM | May 15, 2026

Syneos Health expanded partnerships with causaLens, KAI Conversations, and Sageforce to embed AI agents and causal AI into commercial biopharma workflows.

AstraZeneca Signs Agentic AI Deal With Owkin for Research Automation

By AIM | May 14, 2026

The three-year agreement gives AstraZeneca access to Owkin’s K Pro platform and custom AI agents for clinical and competitive analysis.

GE HealthCare Expands AI-Powered SIGNA MR Platform at ISMRM 2026

By AIM | May 14, 2026

GE HealthCare introduced new AI-powered MRI systems, workflow software, and neuroscience research tools at ISMRM 2026 to accelerate clinical imaging and MR research.

NJHA Partners With Jade Global to Deploy AI Tools Across Hospitals

By AIM | May 12, 2026

The New Jersey Hospital Association and Jade Global will provide hospitals with AI-powered operational tools targeting prior authorization, claims denials, interoperability, and reporting workflows.

Novo Nordisk Transfers Parkinson’s Cell Therapy Program to AI Startup Cellular Intelligence

By AIM | May 12, 2026

Novo Nordisk transferred a clinical-stage Parkinson’s cell therapy program to Cellular Intelligence, which plans to use AI to optimize development and manufacturing.

Quanterix and Tempus Integrate AI-Guided Alzheimer’s Blood Testing

By AIM | May 8, 2026

Quanterix brand Lucent Diagnostics is integrating its Alzheimer’s blood biomarker test into Tempus Next to help neurologists identify eligible patients earlier.

IKS Health Partners With Holyoke Medical Center on AI Operations Platform

By AIM | May 8, 2026

IKS Health and Holyoke Medical Center signed a multi-year partnership focused on reducing administrative burden, improving workflows, and supporting financial sustainability through AI-driven and h...

FDA Launches Elsa 4.0 and HALO to Expand Agencywide AI Operations

By AIM | May 7, 2026

FDA launched Elsa 4.0 and consolidated more than 40 internal systems into HALO as it expands AI-driven regulatory workflows.

Pfizer’s Earnings Reveal the Cost and Complexity of Scaling AI Drug Development

By Mukundan Sivaraj | May 6, 2026

The company is advancing dozens of clinical programs while integrating acquisitions and reducing operational expenses.

RTI International Invests in Navidence to Standardize AI-Driven Real-World Evidence

By AIM | May 6, 2026

RTI International invested in Navidence to standardize disease and treatment definitions in AI-driven real-world evidence research across healthcare and life sciences.

Hartford HealthCare Partners With Cadence To Expand AI Remote Care

By AIM | May 6, 2026

Hartford HealthCare is deploying Cadence’s AI-supported monitoring to extend chronic care into patients’ homes, aiming to accelerate interventions and reduce hospitalizations.

Wellstar Deploys AI Medication Management System With BD Across Hospitals

By AIM | May 5, 2026

Wellstar integrates AI-powered dispensing and infusion systems to improve medication safety, inventory visibility, and clinical workflows.

Essen Health Care Deploys Radin’s AI RIS and PACS Cloud Platform

By AIM | May 4, 2026

The New York-based provider rolls out a unified radiology system aimed at faster reporting, streamlined scheduling, and improved diagnostic workflows.

Oura Just Made the Boldest Femtech Bet of 2026 — And It's Built on AI

By AIM | May 2, 2026

Oura is rolling out Hormonal Birth Control support and Menopause Insights to its global Ring members on May 6 — backed by a proprietary AI model, a clinically-validated questionnaire, and a same-da...

FDA Partners With AstraZeneca and Amgen, Tests Real-Time AI Monitoring of Clinical Trials

By Sachin Mohan | April 30, 2026

"We are boldly advancing a modern approach whereby FDA scientists can view safety signals and endpoints in real time as a trial progresses."

Vir Biotechnology Rebuild Centers On AI-Driven Drug Discovery Platform

By AIM | April 30, 2026

Vir Biotechnology is using AI-driven discovery and protein engineering to expand its oncology pipeline, with a recent Astellas deal reinforcing its platform strategy.

Abbott Receives FDA Clearance, CE Mark for Ultreon 3.0 AI Imaging Platform

By AIM | April 30, 2026

Abbott secured FDA clearance and CE Mark for its Ultreon 3.0 AI-powered OCT platform, designed to guide coronary interventions with real-time imaging insights.

CCS Medical Deploys Enterprise Agentic AI Platform for Chronic Care Support

By Mukundan Sivaraj | April 29, 2026

The company says its CeeCee system will handle 25% of calls and automate up to 80% of intake documents by 2026.

Ochsner Health Joins $15 Million AI Network for Heart Valve Disease Detection

By AIM | April 29, 2026

Ochsner Health joins a $15 million American Heart Association network to use AI in scaling echocardiography screening for early detection of rheumatic heart disease.

Prezent Launches AI and Expert Hybrid Platform for Life Sciences Communications

By Mukundan Sivaraj | April 29, 2026

Prezent introduced Prezent Vivo, combining AI and domain experts to deliver compliant life sciences communications across the full product lifecycle.